Botanical species · safety record

Ammi visnaga

The EFSA Compendium of Botanicals holds 18 constituent measurements and 1 adverse-effect record for Ammi visnaga. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ammi visnaga (L.) Lam.

18Constituent measurements
1Safety records
7Cited sources
21Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 21 licensed products naming Ammi visnaga as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Dried ripe fruit
  • Fruit
  • Fruit(s)
  • Ripe fruit(s)
  • Seed(s)

What the records describe

Constituents measured

  • Khellin6
  • Visnagine5
  • Coumarins3
  • Daidzein1
  • Formononetin1
  • Genistein1
  • Marmesin1

Plant parts

  • Fruit unspecified11
  • Seed6
  • Flowering top2

Preparations

  • Solvent extraction16

Effect types

  • Hepatotoxicity1

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CoumarinsFruit unspecifiedSolvent extraction≤ 1.84 PercentChromatographic testsResolve DOI
CoumarinsFruit unspecifiedSolvent extraction≥ 1.11 PercentChromatographic testsResolve DOI
KhellinFruit unspecifiedSolvent extraction≥ 0.75 PercentChromatographic testsResolve DOI
KhellinSeedSolvent extraction361.9 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
KhellinFruit unspecifiedSolvent extraction≤ 3.03 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
KhellinFruit unspecifiedSolvent extraction≥ 2.27 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
KhellinFruit unspecifiedSolvent extraction1 Microgram/millilitreChromatographic testsResolve DOI
KhellinFruit unspecifiedSolvent extraction≤ 1.01 PercentChromatographic testsResolve DOI
VisnagineSeedSolvent extraction235.7 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
VisnagineFruit unspecifiedSolvent extraction≤ 1.28 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
VisnagineFruit unspecifiedSolvent extraction≥ 0.93 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
VisnagineFruit unspecifiedSolvent extraction≤ 0.46 PercentChromatographic testsResolve DOI
VisnagineFruit unspecifiedSolvent extraction≥ 0.18 PercentChromatographic testsResolve DOI
CoumarinsFlowering topElement spectroscopyNo resolvable identifier
DaidzeinSeedSolvent extraction62.4 Milligram/kilogramUHPLC-MS-MSNo resolvable identifier
FormononetinSeedSolvent extraction6.2 Milligram/kilogramUHPLC-MS-MSNo resolvable identifier
GenisteinSeedSolvent extraction23 Milligram/kilogramUHPLC-MS-MSNo resolvable identifier
MarmesinFlowering topElement spectroscopyNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityDigestiveSeedGallus gallus (chicken) (as animal)SubchronicNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ibrahim, IA., ElBadwi, SMA., Gadir, WSA., Bakhiet, AO., Yagoub, SO., Adam, SEI. Susceptibility of Bovans chicks to low dietary levels of Ammi visnaga and Artemisia herba-alba . Veterinary and human toxicology, 2004, vol. 46, no. 2, p. 67-69.
  2. Abdulmanea, Khaled., Prokudina, Elena A., Lankova, Petra., Vanickova, Lucie., Koblovska, Radka., Zeleny, Vaclav., Lapcik, Oldrich. Immunochemical and HPLC identification of isoflavonoids in the Apiaceae family.. Biochemical systematics and ecology, 2012, vol. 45, p. 237-243.
  3. Baddar, F.G., Farid, S., Starkovsky, N.A. The coumarins of ammi visnaga L. Part I. Their reactions with benzene, toluene, and anisole in presence of aluminium chloride: Isolation of minor constituents of ammi visnaga. Journal of the chemical society (resumed), 1963, p. 4598-4600.
  4. Winderl, Bianca., Schwaiger, Stefan., Ganzera, Markus. Fast and improved separation of major coumarins in Ammi visnaga (L.) Lam. by supercritical fluid chromatography . Journal of separation science, 2016, vol. 39, no. 20, p. 4042-4048. DOI
  5. Pavela, Roman., Vrchotova, Nadezda., Triska, Jan. Larvicidal activity of extracts from Ammi visnaga Linn. (Apiaceae) seeds against Culex quinquefasciatus Say. (Diptera: Culicidae) . Experimental parasitology, 2016, vol. 165, p. 51-57. DOI
  6. Zgorka, G., Dragan, T., Glowniak, K., Basiura, E. Determination of furanochromones and pyranocoumarins in drugs and Ammi visnaga fruits by combined solid-phase extraction-high-performance liquid chromatography and thin-layer chromatography-high-performance liquid chromatography . Journal of chromatography a, 1998, vol. 797, no. 1-2, p. 305-309. DOI
  7. Schimmer, O., Rauch, P. Inhibition of metabolic activation of the promutagens, benzo a pyrene, 2-aminofluorene and 2-aminoanthracene by furanochromones in Salmonella typhimurium . Mutagenesis, 1998, vol. 13, no. 4, p. 385-389. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue